RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation L Codarri, G Gyülvészi, V Tosevski, L Hesske, A Fontana, L Magnenat, ... Nature immunology 12 (6), 560-567, 2011 | 1400 | 2011 |
The end of gating? An introduction to automated analysis of high dimensional cytometry data F Mair, FJ Hartmann, D Mrdjen, V Tosevski, C Krieg, B Becher European journal of immunology 46 (1), 34-43, 2016 | 250 | 2016 |
PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells L Codarri Deak, V Nicolini, M Hashimoto, M Karagianni, PC Schwalie, ... Nature 610 (7930), 161-172, 2022 | 100 | 2022 |
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support A Irmisch, X Bonilla, S Chevrier, KV Lehmann, F Singer, NC Toussaint, ... Cancer Cell 39 (3), 288-293, 2021 | 88 | 2021 |
Proteomics of secretory and endocytic organelles in Giardia lamblia PB Wampfler, V Tosevski, P Nanni, C Spycher, AB Hehl PloS one 9 (4), e94089, 2014 | 47 | 2014 |
The oxysterol synthesising enzyme CH25H contributes to the development of intestinal fibrosis T Raselli, A Wyss, MN Gonzalez Alvarado, B Weder, C Mamie, ... Journal of Crohn's and Colitis 13 (9), 1186-1200, 2019 | 37 | 2019 |
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib SE Gullaksen, J Skavland, S Gavasso, V Tosevski, K Warzocha, ... haematologica 102 (8), 1361, 2017 | 33 | 2017 |
Gamma interferon mediates experimental cerebral malaria by signaling within both the hematopoietic and nonhematopoietic compartments A Villegas-Mendez, P Strangward, TN Shaw, I Rajkovic, V Tosevski, ... Infection and immunity 85 (11), 10.1128/iai. 01035-16, 2017 | 26 | 2017 |
High‐dimensional single‐cell analysis with mass cytometry TM Brodie, V Tosevski Current protocols in immunology 118 (1), 5.11. 1-5.11. 25, 2017 | 23 | 2017 |
OMIP‐045: Characterizing human head and neck tumors and cancer cell lines with mass cytometry TM Brodie, V Tosevski, M Medová Cytometry Part A 93 (4), 406-410, 2018 | 21 | 2018 |
Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression C Lutz, M Mozaffari, V Tosevski, M Caj, P Cippà, BL McRae, CL Graff, ... Clinical & Experimental Immunology 181 (2), 343-356, 2015 | 19 | 2015 |
Mitogen‐activated protein kinase signaling in childhood asthma development and environment‐mediated protection J Theodorou, E Nowak, A Boeck, M Salvermoser, C Beerweiler, K Zeber, ... Pediatric Allergy and Immunology 33 (1), e13657, 2022 | 15 | 2022 |
Identification of ALP+/CD73+ defining markers for enhanced osteogenic potential in human adipose-derived mesenchymal stromal cells by mass cytometry DD Canepa, EA Casanova, E Arvaniti, V Tosevski, S Märsmann, ... Stem Cell Research & Therapy 12, 1-16, 2021 | 13 | 2021 |
Early β‐amyloid accumulation in the brain is associated with peripheral T cell alterations C Gericke, T Kirabali, R Flury, A Mallone, C Rickenbach, L Kulic, ... Alzheimer's & Dementia 19 (12), 5642-5662, 2023 | 10 | 2023 |
Broad immune monitoring and profiling of T cell subsets with mass cytometry TM Brodie, V Tosevski Cellular Heterogeneity: Methods and Protocols, 67-82, 2018 | 6 | 2018 |
CyTOF Mass Cytometry for Click Proliferation Assays V Tosevski, E Ulashchik, A Trovato, P Cappella Current protocols in cytometry 81 (1), 7.50. 1-7.50. 14, 2017 | 5 | 2017 |
Tracking cells and monitoring proliferation V Tosevski, F Mair T-Helper Cells: Methods and Protocols, 51-54, 2014 | 3 | 2014 |
Differentiating PD-1+ stem-like CD8 T cells towards distinct effectors with enhanced therapeutic potential by an engineered IL-2 cis-targeted to PD-1 P Umaña, LC Deak, M Hashimoto, R Ahmed, C Klein, V Nicolini, ... | 1 | 2021 |
Early Β-Amyloid Accumulation in the Brain Is Associated With Blood T and B Cell Alterations C Gericke, T Kirabali, R Flury, A Mallone, C Rickenbach, L Kulic, ... Available at SSRN 3869111, 2021 | 1 | 2021 |
Single-Cell Immune Signatures in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Treated with Nilotinib: An ENEST1st Sub Study SE Gullaksen, J Skavland, K Warzocha, S Gavasso, V Tosevski, ... Blood 126 (23), 4022, 2015 | 1 | 2015 |